AmberGen receives US Patent 10,060,912 for global proteomic screening of random bead-arrays using mass spectrometric imaging.
Company News
![](https://ambergen.com/wp-content/themes/ambergen/img/page-3dots.png)
AmberGen receives US Patent 10,060,912 for global proteomic screening of random bead-arrays using mass spectrometric imaging.